![Jonas Fredrik Röök](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonas Fredrik Röök
Corporate Officer/Principal bij
HANSA BIOPHARMA AB
Profiel
Jonas Fredrik Röök currently works at Hansa Biopharma AB, as Vice President-Business Development from 2026.
Mr. Röök also formerly worked at Isofol Medical AB, as Director-Business Development, KDventures AB, as Director-Business Development, H.
Lundbeck A, as Head-Regulatory Product Strategy, and Calabar AB, as Vice President-Business Development.
Actieve functies van Jonas Fredrik Röök
| Bedrijven | Functie | Begin |
|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 17-08-2026 |
Eerdere bekende functies van Jonas Fredrik Röök
| Bedrijven | Functie | Einde |
|---|---|---|
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
| KDVENTURES AB | Corporate Officer/Principal | - |
| ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Calabar AB
 Calabar AB Medical SpecialtiesHealth Technology Develops pharmaceutical products | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
21
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Calabar AB
Calabar AB Medical SpecialtiesHealth Technology Develops pharmaceutical products | Health Technology |
Isofol Medical AB
 Isofol Medical AB Pharmaceuticals: MajorHealth Technology Provides novel folate-based pharmaceutical products | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
